Current and historical daily PE Ratio for Rhinomed Ltd (
ASX:RNO
) from 2007 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Rhinomed stock (ASX:RNO) PE ratio as of May 15 2024 is 0.
More Details
Rhinomed Ltd (ASX:RNO) PE Ratio (TTM) Chart
Rhinomed Ltd (ASX:RNO) PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Total 1206
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Rhinomed PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-15 | At Loss | 2023-12-12 | At Loss |
| 2024-02-16 | At Loss | 2023-12-11 | At Loss |
| 2024-02-15 | At Loss | 2023-12-08 | At Loss |
| 2024-02-14 | At Loss | 2023-12-07 | At Loss |
| 2024-02-13 | At Loss | 2023-12-06 | At Loss |
| 2024-02-12 | At Loss | 2023-12-05 | At Loss |
| 2024-02-09 | At Loss | 2023-12-04 | At Loss |
| 2024-02-08 | At Loss | 2023-12-01 | At Loss |
| 2024-02-07 | At Loss | 2023-11-30 | At Loss |
| 2024-02-06 | At Loss | 2023-11-29 | At Loss |
| 2024-02-05 | At Loss | 2023-11-28 | At Loss |
| 2024-02-02 | At Loss | 2023-11-27 | At Loss |
| 2024-02-01 | At Loss | 2023-11-24 | At Loss |
| 2024-01-31 | At Loss | 2023-11-23 | At Loss |
| 2024-01-30 | At Loss | 2023-11-22 | At Loss |
| 2024-01-29 | At Loss | 2023-11-21 | At Loss |
| 2024-01-25 | At Loss | 2023-11-20 | At Loss |
| 2024-01-24 | At Loss | 2023-11-17 | At Loss |
| 2024-01-23 | At Loss | 2023-11-16 | At Loss |
| 2024-01-22 | At Loss | 2023-11-15 | At Loss |
| 2024-01-19 | At Loss | 2023-11-14 | At Loss |
| 2024-01-18 | At Loss | 2023-11-13 | At Loss |
| 2024-01-17 | At Loss | 2023-11-10 | At Loss |
| 2024-01-16 | At Loss | 2023-11-09 | At Loss |
| 2024-01-15 | At Loss | 2023-11-08 | At Loss |
| 2024-01-12 | At Loss | 2023-11-07 | At Loss |
| 2024-01-11 | At Loss | 2023-11-06 | At Loss |
| 2024-01-10 | At Loss | 2023-11-03 | At Loss |
| 2024-01-09 | At Loss | 2023-11-02 | At Loss |
| 2024-01-08 | At Loss | 2023-11-01 | At Loss |
| 2024-01-05 | At Loss | 2023-10-31 | At Loss |
| 2024-01-04 | At Loss | 2023-10-30 | At Loss |
| 2024-01-03 | At Loss | 2023-10-27 | At Loss |
| 2024-01-02 | At Loss | 2023-10-26 | At Loss |
| 2023-12-29 | At Loss | 2023-10-25 | At Loss |
| 2023-12-28 | At Loss | 2023-10-24 | At Loss |
| 2023-12-27 | At Loss | 2023-10-23 | At Loss |
| 2023-12-22 | At Loss | 2023-10-20 | At Loss |
| 2023-12-21 | At Loss | 2023-10-19 | At Loss |
| 2023-12-20 | At Loss | 2023-10-18 | At Loss |
| 2023-12-19 | At Loss | 2023-10-17 | At Loss |
| 2023-12-18 | At Loss | 2023-10-16 | At Loss |
| 2023-12-15 | At Loss | 2023-10-13 | At Loss |
| 2023-12-14 | At Loss | 2023-10-12 | At Loss |
| 2023-12-13 | At Loss | 2023-10-11 | At Loss |
Rhinomed Ltd (ASX:RNO) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Rhinomed Ltd
ISIN : AU000000RNO1
Description
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers